Soltany P, Miralinaghi M, Pajoum Shariati F. Folic acid conjugated poly (Amidoamine) dendrimer grafted magnetic chitosan as a smart drug delivery platform for doxorubicin: In-vitro drug release and cytotoxicity studies.
Int J Biol Macromol 2024;
257:127564. [PMID:
37865361 DOI:
10.1016/j.ijbiomac.2023.127564]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2023] [Revised: 09/27/2023] [Accepted: 10/18/2023] [Indexed: 10/23/2023]
Abstract
This study reports the development of a magnetic and pH-responsive nanocarrier for targeted delivery and controlled release of doxorubicin (DOX). A multifunctional magnetic chitosan nanocomposite (FA-PAMAMG2-MCS) was fabricated by grafting poly(amidoamine) dendrimer and folic acid onto the MCS surface for active targeting. DOX was loaded into this core-shell bio-nanocomposite via adsorption. Structural and morphological characterization of the prepared nanomaterials was performed using XRD, FT-IR, VSM, TGA, BET, FE-SEM/EDX, and TEM techniques. Adsorption capacity of the FA-PAMAMG2-MCS was optimized by changing diverse parameters, such as pH, initial drug concentration, temperature, contact time, and adsorbent dosage. The maximum adsorption capacity for DOX was 102.85 mg g-1 at 298 K. The in-vitro drug release curve at pHs 5.6 and 7.4 manifested a faster drug release from the prepared nanocarrier in acidic environments and, conversely, a slower release in neutral environments over 48 h. The release kinetics followed Peppas-Sahlin models, showing non-Fickian behavior. Moreover, the in-vitro cytotoxicity studies against the human breast cancer (MDA-MB 231) cell line demonstrated the remarkable anticancer activity of the DOX@FA-PAMAMG2-MCS and declared its potency for nanomedicine applications. This multifunctional system could overcome limitations of conventional chemotherapeutic agents through pH-triggered drug release, enabling targeted cytotoxicity against cancer cells.
Collapse